Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)

NCT02568722 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT02568722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02568722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
Lead sponsor
Unity Health Toronto
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2015
Completion date
December 31, 2019
Enrollment
3,019 (actual)
Sites
105

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury